Biofrontera (BFRI) Total Non-Current Liabilities (2020 - 2026)
Biofrontera (BFRI) recorded Total Non-Current Liabilities of $17.58 million in Q2 2026, down 27.5% from $24.26 million a year earlier.
Powered by 
Analysis
Biofrontera (BFRI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2025, Biofrontera reported Total Non-Current Liabilities of $17.73 million, up 8.0% from FY2024.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $16.42 million in FY2024 (-13.3%), $18.93 million in FY2023 (-21.7%), $24.16 million in FY2022 (-16.8%) and $29.03 million in FY2021 (+59.1%).
- Quarterly Total Non-Current Liabilities has ranged from $9.74 million in Q2 2024 to $29.03 million in Q4 2021 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities rose in three of the last seven quarters, with growth averaging 14.3%.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 149.0% in Q2 2025, against a decline of 51.3% in Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Biofrontera | 16.05 Mn | -5.74 Mn | 9.59 Mn | 17.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.58 Mn |
| Dec 31, 2025 | 17.73 Mn |
| Sep 30, 2025 | 17.16 Mn |
| Jun 30, 2025 | 24.26 Mn |
| Mar 31, 2025 | 15.42 Mn |
| Dec 31, 2024 | 16.42 Mn |
| Sep 30, 2024 | 11.39 Mn |
| Jun 30, 2024 | 9.74 Mn |
| Mar 31, 2024 | 18.26 Mn |
| Dec 31, 2023 | 18.93 Mn |
| Sep 30, 2023 | 23.36 Mn |
| Mar 31, 2023 | 15.98 Mn |
| Dec 31, 2022 | 24.16 Mn |
| Sep 30, 2022 | 23.51 Mn |
| Jun 30, 2022 | 28.35 Mn |
| Mar 31, 2022 | 26.13 Mn |
| Dec 31, 2021 | 29.03 Mn |
| Sep 30, 2021 | 23.43 Mn |
| Dec 31, 2020 | 18.25 Mn |
API Access
Biofrontera Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BFRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "BFRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BFRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();